FR2358155B1 - - Google Patents

Info

Publication number
FR2358155B1
FR2358155B1 FR7720737A FR7720737A FR2358155B1 FR 2358155 B1 FR2358155 B1 FR 2358155B1 FR 7720737 A FR7720737 A FR 7720737A FR 7720737 A FR7720737 A FR 7720737A FR 2358155 B1 FR2358155 B1 FR 2358155B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7720737A
Other languages
French (fr)
Other versions
FR2358155A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2942176A external-priority patent/GB1561037A/en
Application filed by Individual filed Critical Individual
Publication of FR2358155A1 publication Critical patent/FR2358155A1/fr
Application granted granted Critical
Publication of FR2358155B1 publication Critical patent/FR2358155B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7720737A 1976-07-15 1977-07-06 Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses Granted FR2358155A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2942176A GB1561037A (en) 1976-07-15 1976-07-15 Composition for the treatment and prevention of skin eye and mucosal inflammation
GB1967877 1977-05-11

Publications (2)

Publication Number Publication Date
FR2358155A1 FR2358155A1 (fr) 1978-02-10
FR2358155B1 true FR2358155B1 (cg-RX-API-DMAC7.html) 1980-02-01

Family

ID=26254187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720737A Granted FR2358155A1 (fr) 1976-07-15 1977-07-06 Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses

Country Status (3)

Country Link
US (1) US4208406A (cg-RX-API-DMAC7.html)
DE (1) DE2732179A1 (cg-RX-API-DMAC7.html)
FR (1) FR2358155A1 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949217C2 (de) * 1979-12-07 1984-03-01 Jörn Prof. Dr. 2072 Jersbek Bethge Arzneimittel mit Callusbildung und Wundheilung fördernder Wirkung
US4369181A (en) * 1981-08-05 1983-01-18 Sri International Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4956348A (en) * 1986-02-19 1990-09-11 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with cyclic nucleotides
DE3786714T2 (de) * 1986-06-16 1994-03-10 Daiichi Seiyaku Co Therapeutisches Mittel für Hautgeschwüre.
US5376643A (en) * 1986-09-18 1994-12-27 Lion Corporation Composition for application to hair
US6919320B1 (en) 1987-10-28 2005-07-19 Wellstat Therapeutics Corporation Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US6348451B1 (en) 1987-10-28 2002-02-19 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
US6020322A (en) * 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US6743782B1 (en) 1987-10-28 2004-06-01 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
ATE243039T1 (de) * 1987-10-28 2003-07-15 Wellstat Therapeutics Corp Acyldeoxyribonukleosid-derivate und verwendungen davon
CA1322957C (en) * 1988-03-30 1993-10-12 Hitoshi Yamauchi Cyclic amp derivative ointments
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
WO1989011487A1 (en) * 1988-05-23 1989-11-30 United States Of America, Represented By The Secre Derivatives of cyclic amp as treatment for cancer
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US7169765B1 (en) 1988-10-27 2007-01-30 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
FR2649610B1 (fr) * 1989-07-13 1994-06-03 Dior Christian Parfums Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
US6033665A (en) * 1989-09-27 2000-03-07 Elan Pharmaceuticals, Inc. Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
US5260210A (en) * 1989-09-27 1993-11-09 Rubin Lee L Blood-brain barrier model
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
AU657033B2 (en) * 1992-01-27 1995-02-23 Daiichi Pharmaceutical Co., Ltd. Cyclic AMP derivative-containing ointment
WO1993021929A1 (en) * 1992-05-01 1993-11-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Phosphorothioate derivatives of cyclic amp analogues
ZA961081B (en) * 1995-02-10 1996-10-15 Schering Ag Pharmaceutical preparations for tnf inhibition
DE19540475A1 (de) * 1995-10-20 1997-04-24 Schering Ag Chirale Methylphenyloxazolidinone
US6531140B2 (en) * 1999-05-04 2003-03-11 E-L Management Anti-irritant compositions containing a cyclic nucleotide
US20030026794A1 (en) * 2001-07-31 2003-02-06 Howard Fein Selective enzyme treatment of skin conditions
GB0501476D0 (en) * 2005-01-25 2005-03-02 Heptagen Ltd Treatment for mucositis
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336441A (en) * 1969-10-10 1973-11-07 Anvar Derivatives of cyclo adenosine-3,5-phosphoric acid and their preparation
JPS497414A (cg-RX-API-DMAC7.html) * 1972-05-24 1974-01-23
GB1426479A (en) * 1972-07-10 1976-02-25 Nelson Research Dev Co Dermatological composition and method

Also Published As

Publication number Publication date
FR2358155A1 (fr) 1978-02-10
DE2732179A1 (de) 1978-01-19
US4208406A (en) 1980-06-17

Similar Documents

Publication Publication Date Title
FR2358155B1 (cg-RX-API-DMAC7.html)
FI772303A7 (cg-RX-API-DMAC7.html)
FR2354774B1 (cg-RX-API-DMAC7.html)
FR2342980B3 (cg-RX-API-DMAC7.html)
JPS541911Y2 (cg-RX-API-DMAC7.html)
JPS52151478U (cg-RX-API-DMAC7.html)
JPS52151646U (cg-RX-API-DMAC7.html)
JPS5318402U (cg-RX-API-DMAC7.html)
JPS5550386Y2 (cg-RX-API-DMAC7.html)
JPS5444617B2 (cg-RX-API-DMAC7.html)
JPS52135648U (cg-RX-API-DMAC7.html)
JPS5337420U (cg-RX-API-DMAC7.html)
JPS52163693U (cg-RX-API-DMAC7.html)
JPS5298979U (cg-RX-API-DMAC7.html)
JPS52137652U (cg-RX-API-DMAC7.html)
JPS5331861U (cg-RX-API-DMAC7.html)
JPS5349423U (cg-RX-API-DMAC7.html)
JPS52151883U (cg-RX-API-DMAC7.html)
CS177772B1 (cg-RX-API-DMAC7.html)
DD125563A1 (cg-RX-API-DMAC7.html)
DD123710A1 (cg-RX-API-DMAC7.html)
DD126042A1 (cg-RX-API-DMAC7.html)
DD125897A1 (cg-RX-API-DMAC7.html)
DD125844A1 (cg-RX-API-DMAC7.html)
DD127038A1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
MD Transfer of rights in case of death
TP Transmission of property
TP Transmission of property
ST Notification of lapse